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Abstract
Purpose Perceived health (PH) is a subjective measure of
global health of individuals. While many studies have evalu-
ated outcomes in patients with primary immune deficiency
(PID), published literature evaluating PH among patients with
PID is sparse. We evaluated the results of the largest self-
reported survey of patients with PID to determine the factors
that may contribute to differences in PH.
Methods Data from a National Survey of Patients with Prima-
ry Immune Deficiency Diseases conducted by the Immune
Deficiency Foundation was studied. Multivariate logistic re-
gression was employed for data analysis.
Results Thirty percent of the patients perceived their health
status as excellent or very good (EVG), 31% as good (G), and
39 % as fair, poor or very poor (P). Older patients were less
likely to have EVG-PH compared to G-PH. Ones with college
degrees were more likely to have P-PH compared to G-PH,
and less likely to have EVG-PH. Patients who were acutely ill
and hospitalized in the past 12 months, ones with limited
activity, and chronic diseases, were more likely to have P-
PH compared to G-PH. Patients with Bon demand^ access to
specialty care and ones on regular IVIG had higher OR of
having EVG-PH as opposed to G-PH. Patients cared for
mostly by an immunologist were less likely to have P-PH
compared to G-PH.
Conclusions Our results emphasize the importance of PH in
clinical practice. We suggest that recognizing the factors that
drive PH in patients with PID is important for the develop-
ment of disease prevention and health promotion programs,
and delivery of appropriate health and social services to indi-
viduals with PID.
Keywords Perceived health . health status . primary immune
deficiency . health survey . immunoglobulin
Introduction
Perceived health is a subjective measure of global health
of individuals. There is a clear difference between the real
PH assessments and questions regarding the prevalence of
diseases. The PH assessment reflects individuals’ integrat-
ed PH, including the biological, psychological, cultural,
and social dimensions, which is inaccessible to any exter-
nal observer [1–3]. In other words, they cannot be easily
detected by health care professionals. Perceived health
status has been extensively used in epidemiologic studies
as a broad indicator of health-related well-being [4–6]. It
is an important predictor of a number of outcomes, such
as new morbidity, functional ability, health care utilization
[7,8], recovery from illness [9], and physician ratings of
health [10]. It may encompass aspects that are difficult to
capture clinically, such as incipient disease, physiological
and psychological reserves, and social function [11–13].
Moreover, it is an important and reliable indicator of qual-
ity of care as well as patient satisfaction, and quality im-
provement [14]. Existing evidence supports that patients
in better health tend to report greater satisfaction with
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their health status and health care than patients in poor
health [15]. Numerous epidemiological studies have re-
ported an association between PH and mortality from all
causes [3,16–19] while others have shown it to be asso-
ciated with specific chronic diseases such as musculoskel-
etal, cardiovascular, and psychiatric disorders [20]. Per-
ceived health may be influenced by age and gender dif-
ferences as well as social, environmental and personal
factors [1,21]. For example, individuals who consider
themselves to be in poor health may be more likely de-
pressed, may have disabilities, may be leading less pro-
ductive and fulfilling lives, or may not be receiving the
health care that they need.
Perceived health, also known as Bself-assessed health^,
Bself-rated health^, Bself-evaluated health^, or Bsubjective
health^, has been evaluated and described in several patient
populations with chronic conditions including systemic lupus
erythematous [22], chronic obstructive pulmonary disease
[23], inflammatory bowel disease [24], asthma [25], and
cancer [14]. However, published literature evaluating
patient-reported outcome measures related to patients with
PID is sparse [26,27], and none have specifically analyzed
PH. As a chronic disease, complications of PID bring
about major challenges to health and social life of indi-
viduals affected by it. Understanding the health status of
this population and the factors driving it is important for
the development of disease prevention and health promo-
tion programs, as well as the delivery of appropriate
health and social services to individuals with PID. There-
fore, we aimed to describe general characteristics and
health of a national U.S. sample of patients with a variety
of PID diagnoses, and define the variables that influenced
PH among patients with PID.
Methods
Data Source
Investigations were based on data obtained from the Second
National Survey of Patients with Primary Immune Deficiency
Diseases in America, which was conducted by the Immune
Deficiency Foundation (IDF) in 2002. The IDF contact data-
base provided the first stage in the construction of the sam-
pling frame. This large national sample consisted of 5922
adults and children with PID across U.S. Patients were mailed
a two-page self-administered questionnaire, along with a cov-
er letter explaining the purposes of the survey. A total of 1587
individuals completed and returned the questionnaire
(26.8 %). 49 cases were identified as deceased patients with
PID, and the remainder was patients without PID but with
other diagnoses such as autoimmune disease. Therefore data
were collected from only 1526 patients with PID.
Variables of Interest
The outcome measure, perceived health status, was assessed
on a 6-point Likert scale (1=excellent, 2=very good, 3=good,
4=fair, 5=poor, 6=very poor) based on the question BWould
you describe his/her current health status as excellent, very
good, good, fair, poor, or very poor?^. The excellent and very
good response categories, as well as the fair to very poor
categories were combined, creating three comparison groups:
excellent to very good (EVG), good (G), and fair to very poor
which is referred to hereafter as poor-rated (P) health. Each
indicator of PH status was coded according to a trinomial
outcome variable (0=good, 1=excellent /very good, 2=fair/
poor/very poor). Independent variables were grouped into the
following: Sociodemographic, PID diagnosis (type), current
health status, comorbidities, health care access, and IVIG
treatment. The sociodemographic variables included: age, gen-
der, education status (less than college, college and higher),
questionnaire respondent (adult patient, parent/caregiver,
both), employment status (unemployed, employed, other),
and number of children with PID in the household (none vs.
at least one). The very first question asked who the respondent
was in relation to a patient with a PID. If there were no children
in the household with PID, it was instructed that patients with
PID should answer about themselves. If they were not patients
with PID then it was instructed that they should answer ques-
tions about the oldest child in the household with PID.
Patient sample had a number of PID diagnoses, and includ-
ed common variable immunodeficiency (CVID), IgA defi-
ciency, IgG subclass deficiency, X-linked agammaglobulin-
emia (XLA), severe combined immunodeficiency (SCID),
chronic granulomatous disease (CGD), Hyper IgM Syndrome
(HIM), Wiskott Aldrich Syndrome (WAS), and DiGeorge
Syndrome (DGS) (Fig. 1). Common variable immunodefi-
ciency accounted for the majority of the patient sample (about
54 %), followed by IgG subclass and IgA deficiencies, and all
other diagnoses were smaller proportions. Because of the large
distribution differences within PID diagnoses, and CVID
comprising the majority of the diagnoses we observed a better
fit in logistic regression modeling when diagnoses were
reclassified in two groups (CVID vs. non-CVID). Therefore
items related to PID diagnosis were assessed as follows: hav-
ing CVID (yes/ no), having a family member with PID (yes/
no), having infections prior to diagnosis with PID (yes/ no),
reason for initial testing for PID (family history, routine check-
up, recurrent infections, unusual infections, serious infec-
tions), and number of hospitalizations prior to diagnosis with
PID (none vs. at least one). Current health was elucidated
through three questions and included: having acute illness in
the past 12 months (yes/ no), hospitalization in the past
12 months (yes/ no), and limitation of physical activity (none,
slight, moderate, severe). Comorbidities included: having per-
manent functional impairment (yes/ no), other chronic disease
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(yes/ no), cancer/leukemia (yes/ no), hepatitis (yes/ no), or
neurological disease (yes/ no). Health care access was
assessed by five questions and included: physician visited
most often for health care (specialist in immunology vs. other
specialist), setting of primary care visit (private office vs.
others), having Bon demand^ access to specialist care as need-
ed (yes/ no), having visited immunologist in the past
12 months (yes/ no), insurance status (private vs non-private).
Treatment status with IVIG was assessed by the following
questions: ever receiving IVIG on a regular basis (yes/no),
length of regular IVIG treatment, current treatment status with
IVIG (yes/no), frequency of IVIG treatment (every 2 weeks or
more often, every 3 weeks, every 4 weeks, every 5 weeks,
every 6 weeks or more), side effects of IVIG treatment (yes/
no). Because the data related to IVIG treatment was sparse
(<15 %) (except for the question that addressed whether the
patient has ever received regular treatment with IVIG), other
variables of IVIG treatment were excluded from the analysis.
Statistical Analysis
To model our multinomial scaled outcome, we employed the
backwards eliminationmethod to build ourmultinomial logistic
regression model using Stata 12 (StataCorp, Inc., College
Station, TX). We first conducted a univariable analysis of all
the non-sparse variables, defined as variables with less than an
85 % response rate, and retained the covariates with a p-value
less than 0.25. After determining the variables that belonged in
our preliminary main effects model, we assessed whether age
could be kept in the model as a continuous variable. We found
that age in years was not linear and, thus, could not remain as a
continuous variable in the model. Using the average age of our
sample population as the cut-off point, we dichotomized age
into less than 33 years old and greater than 33 years old.
Our final multinomial logistic regression model included
covariates for age, gender, education, CVID diagnosis,
infection prior to diagnosis, acute illness in the past 12months,
limitation, hospital stay in the past 12 months, hepatitis, other
chronic diseases (not counting primary immune deficiency),
access to care as needed, primary health care provider special-
ty, and ever having received regular IVIG treatments. To test
how well our model fits the observed values in the IDF ques-
tionnaire, we ran the Hosmer-Lemeshow goodness of fit test.
The Hosmer-Lemeshow goodness of fit test is a measure of
lack of fit of our logistic regression model. Thus, rejection of
the null hypothesis for the Hosmer-Lemeshow goodness of fit
test indicates that the model we have built adequately fits our
data.
When comparing patients who had EVG-PH versus pa-
tients who had G-PH, the summary goodness-of-fit statistic
was 8.89 (degrees of freedom [df]=8, p-value=0.3519). For
patients who had P-PH versus patients who had G-PH, the
summary goodness-of-fit statistic was 11.70 (df=8, p-val-
ue=0.1653). For both of these strata, the p-values indicate that
we must reject the null hypothesis that the model is not a good
fit to our data. Thus, we can conclude that our model is a good
overall fit to the data.
Results
Of the 1526 PID survey respondents, 61.2 % were adult PID
patients, 36.7% were parents of a PID patient, and 2.1 %were
both adult PID patients and parents of a PID patient (Table 1).
In cases where there was more than one person with PID in a
household, it was necessary to direct the survey recipient on
how to select a designated respondent for the survey. Thus, the
questionnaire specified that if an adult patient had children
with PID, the adult patient should answer the survey ques-
tions, rather than their affected children. If there were multiple
children with PID in the household, and no adult patients with
PID, the parent/caregiver was directed to answer the survey
questions about the oldest child with PID. The reason for this
selection procedure was to provide a sample with the longest
diagnosis and treatment experience.
The vast majority of PID patients were White, non-
Hispanic (93.7 %). Approximately one-third of the patients
were younger than 18 years old and another third were young
adults between 18 and 44 years old with mean age of 33 years
(SD ±20.2). The geographic distribution of the patient sample
closely mirrored the total population of U.S. In comparing the
proportion of the U.S. born patients who were born in a par-
ticular Census division to the percent of the U.S. population
living in that division, the rates were almost identical for New
England, Mid-Atlantic, South Atlantic, East and West South
Central, and Mountain (Fig. 2).
More than half of the patients were females, which was
similar to the general population. The majority of respondents
(73 %) had completed college. Fifty four percent of the
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Fig. 1 National Survey of Patients with Primary Immune Deficiency,
2002: Primary Immune Deficiency Diagnoses
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patients were employed, 21.9 % were unemployed, and the
others were homemakers, students, or did not respond with an
employment status. Thirty percent of the patients perceived
their health status as excellent or very good, 31% as good, and
39 % as fair, poor or very poor.
A patient’s PH status, which divided the respondents into
approximate thirds (excellent/very good, good, and fair/poor),
was used to characterize univariate associations between
the characteristics of patients with PID. Perceived health
was significantly linked to sociodemographic characteristics
including age, gender, education level, type of respondent,
and employment status (Table 2). When evaluating the
sociodemographic characteristics of PID patients with regards
to PH 47.5 % of women, but only 29.6 % of men, reported
P- PH (p<0.0001). Conversely, a higher percentage of men
than women described their health as excellent or very good
(39.4 % and 22.4 %, respectively). Older patients were more
likely to report P- PH, although this was difficult to separate
from reporting by a caretaker as opposed to the patients them-
selves (p<0.0001). More patients with a college degree had
poorer PH when compared to those with less education.
Homemakers and students had poorer PH than employed pa-
tients and non-homemaker unemployed patients (p<0.0001).
Households with a child having PID had better PH when
compared to those without any child with PID (39.3 and
22.8 %, respectively, p<0.001). Conversely, households with-
out a child having PID reported poorer PH when compared to
those with a child having PID (47.8 and 28.7 %, respectively,
p<0.0001).
In addition, PH (in either direction) was significantly asso-
ciated with a number of other patient characteristics including
the number of children with PID in the household, CVID
diagnosis, infections prior to diagnosis, reason for initial test-
ing for PID, number of hospitalizations prior to diagnosis with
PID, presence of acute illnesses and hospitalization in the past
12months, limitation of daily physical activity, comorbid con-
ditions, Bon demand^ access to specialist care, the specialty of
the physician caring for the patient (immunologist versus oth-
er specialty), and possession of health insurance (Table 3).
Having had a visit with immunologist in the past 12 months,
the particular setting of physician visits (i.e., doctor’s office,
clinic, or hospital), and whether or not the patient has ever
received regular IVIG replacement therapy were not signifi-
cantly associated with PH when considered as individual var-
iables (Table 3).
Since our outcome variable is trinomial (i.e., three levels of
PH), we used a multivariate logistic regression analysis ap-
proach to determine if there were significant drivers of PH in
light of all of the potentially mitigating and confounding var-
iables. These were calculated as odds ratios (OR) together
with their 95 % confidence intervals (CI). Using backwards
elimination, all covariates with a p value of less than 0.25 in
the univariate analysis were included in the preliminary mul-
tivariate model, and the model was constructed by eliminating
the variables, one at a time, based on lack of significance in the
presence of other covariates. This method of elimination con-
tinued until all variables in the remaining model with either
significant or deemed clinically significant. Thus, the final
multivariate model included age, gender, education status,
having a diagnosis of CVID, infections prior to diagnosis with
PID, acute illness and hospitalization in the past 12 months,
limitation of physical activity, hepatitis, chronic diseases, Bon
demand^ access to specialist care, the specialty of the physi-
cian caring for the patient and having ever received regular
IVIG treatment (Table 4). When all of these factors that might
impact PHwere taken into consideration and adjusted ORs are
















8th grade or less 90 (6)
Some high school 45 (3)
Completed high school 270 (18)
Some college 464 (31)
Completed college 345 (23)










Parent of a child with PID 558 (36.7)
Both 32 (2.1)
Perceived health
Excellent/very good 444 (30)
Good 459 (31)
Fair/poor/very poor 601 (39)
J Clin Immunol (2015) 35:638–650 641
calculated, significant associations between PH and gender,
respondent type, employment status, CVID diagnosis, infec-
tions and number of hospitalizations prior to PID diagnosis,
reason for initial testing for PID, all comorbidities except
chronic diseases, and insurance status were no longer
observed.
Some covariates, however, did survive multivariate analy-
ses and thus remain as potentially independent drivers of PH.
Age was associated with PH, but only when comparing EVG-
PH to G-PH. Respondents 33 years of age and older had lower
odds of having EVG- PH (OR 0.68, 95 %CI 0.48–0.98;
p=0.037 as opposed to G-PH. Of note, 95.8 % of patients
33 years of age and older were adult patients (data not shown).
Perceived health and education level were significantly as-
sociated. PID patients with a college degree were more likely
to have P-PH as opposed to G-PH (OR 1.54, 95 %CI 1.12–
2.13; p=0.008) and less likely to report EVG-PH (OR 0.65,
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Fig. 2 Distribution of 1997 and 2002 National Survey of Patients with PID and overall US population by region
Table 2 Comparison of
sociodemographic characteristics












Age (mean year±SD) 1479 25.4 (±18.3) 0.0001 31.8 (±20) 39.5 (±19.4) 0.0001
Gender 1497
Male (%)* 39.4 31.0 29.6
Female (%) 22.4 0.0001 30.2 47.5 0.0001
Education 1476
Less than college (%)* 25.5 29.9 44.6
College & higher (%) 34.8 0.047 31.3 33.9 0.012
Questionnaire respondent 1499
Adult (%)* 22.9 29.5 47.6
Parent (%) 44.4 0.0001 31.7 26.9 0.0001
Both (%) 13.3 0.109 43.3 43.3 0.231
Employment 1464 0.0001
Unemployed (%)* 36.5 34.3 29.3
Employed (%) 36.7 0.99 34.5 28.9 0.900
Other (%) 6.4 0.0001 18.9 74.8 0.0001
No of children with
PID in household
1504
None (%)* 22.8 29.4 47.8 0.0001
At least one (%) 39.3 0.001 32 28.7 0.0001
*Reference
Significance level p<0.05












Characteristics N % % %
Diagnosis
CVID 1504 0.003 0.006
No* 17.1 14.6 15.8




No * 22.7 24 31.1




No* 4.3 2.4 2




Family history* 2.8 1.3 1.8
Check-up 3.7 0.002 4.9 5.4 0.56
Recurrent infection 13.5 0.006 14.1 18.1 0.87
Unusual infections 2 0.48 1.3 2.2 0.54
Serious infections 3.7 0.001 5.3 6.5 0.75
Other 3.7 0.025 3.7 6.1 0.55
No of hospitalizations
prior to PID diagnosis
1402
None* 14.8 13.7 12.6
1–3 11 0.81 10.6 9.8 0.97
4–6 2.4 0.07 3.5 7.3 0.0001
>6 3.4 0.04 4.9 13 0.0001
Current Health
Acute illness in past
12 months
1504 0.0001 0.0001
No* 14 6.2 3.6




No* 24.5 21.2 23.9




None* 21 8.3 1.5
Slight 7.3 0.0001 14.3 8.4 0.0001
Moderate 1.1 0.0001 6.5 17.3 0.0001





No* 23 2.1 18.9
Yes 6.5 9.9 21.1
Other chronic disease 1467 0.0001 0.0001
No* 21.1 14.2 9.7
Yes 8.9 16.3 29.9
Cancer/leukemia 1495 0.12 0.004
No* 28.4 28.8 35.3
Yes 1.1 1.9 4.5
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The occurrence of acute illness and hospitalization within
the last 1 year were significantly associated with P-PH. Patients
who were acutely ill and hospitalized in the past 12 months
were more likely to have poor as opposed to G-PH (OR 1.20,
95 %CI 1.24–3.21; p=0.005 and OR 1.48, 95 %CI 1.05–2.07;
p=0.025, respectively), and less likely to have EVG-PH (OR
0.45, 95 %CI 0.32–0.64; p<0.0001, and OR 0.53, 95 %CI
0.36–0.77; p<0.001, respectively). A strong association was
observed between PH and the limitation of physical activity as
patients with restrictions had higher odds of reporting P-PH,
and lower odds of describing EVG-PH. More strikingly,
patients had worse PH if they had more limitation of physical
activity. Patients with severe limitation had 51.37 times higher
odds of having P-PH (OR 51.37, 95 %CI 24.11–109.41;
p<0.001) as opposed to moderate limitation (OR 14.16,
95 %CI 7.92–25.31; p<0.001). The degree of limitation was
also relevant as those with slight limitation as opposed to ones
without limitation had worse PH (OR 2.92, 95 %CI 1.66–5.14;
p<0.0001).
Chronic disease also influenced health perception as patients
with chronic disease such as bronchitis, malabsorption, and
recurrent infections were more likely to have P-PH (OR 1.70,
95 %CI 1.21–2.36; p=0.002) as opposed to EVG-PH (OR 0.56,
95%CI 0.40–0.78; p=0.001). Patients with Bon demand^ access
to specialist care had 2.54 higher odds of reporting EVG-PH as
opposed to G-PH (OR 2.54, 95 %CI 1.27–5.06; p=0.008). An
association between PH and Bon demand Baccess to specialty
care, however, was not observed when comparing P-PH to G-
PH. Patients who were most often seen by an immunologist for
care, however, (when compared to other specialties) were sig-
nificantly less likely to have P-PH (OR 0.68, 95 %CI 0.49–
0.94; p=0.020). Finally, patients who were receiving regular
IVIG replacement therapy were more likely to have EVG-PH








Hepatitis 1483 0.05 0.006
No 28.7 28.9 35.3
Yes 0.9 1.8 4.3
Neurological disease 1469 0.0001 0.0001
No 27 25.1 25.9
Yes 2.9 5.7 13.5
Health care access
Physician specialty 1504 0.24 0.06
Other 18.5 18 25.8




Private office* 19.2 20.1 27.1




No* 1.1 3.1 6.8
Yes 28.5 27.2 33.3
Visit with immunologist
in past 12 months
1495 0.45 0.80
No* 9 8.6 11.6
Yes 20.6 21.8 28.4
Insurance status 1487 0.0001 0.002
Private* 26.2 23.5 21.9
Non-private 3.5 6.8 17.1
None 0.07 0.3 0.7
Treatment
Regular IVIG treatment 1500 0.97 0.11
No* 6.5 6.8 7.3
Yes 23 23.8 32.6
*Reference
Significance level p<0.05
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Discussion
We used the results from the National Survey of Patients with
Primary Immune Deficiency Diseases in America, conducted
by the IDF, in an attempt to gain a better understanding of the
drivers of PH among patients with PID. Our survey sample
was nationally distributed, and based on the single, largest
database of persons with PID in the world. Additionally, the
Table 4 Results of multivariate
logistic regression: Adjusted ORs
relating variables to excellent/
very good PH and fair/poor/very
poor versus good PH in patients
with PID




OR (95 % CI) p OR 95%CI p
Age (year) <33* 1.0 1.0
≥33 0.68(0.48–0.98) 0.037 1.11(0.78–1.57) 0.562
Gender
Male* 1.0 1.0
Female 1.02(0.73–1.43) 0.896 0.87(0.62–1.24) 0.447
Education
Less than college* 1.0 1.0
College & higher 0.65(0.46–0.90) 0.009 1.54(1.12–2.13) 0.008
CVID
No * 1.0 1.0
Yes 0.72(0.51–1.02) 0.066 1.35(0.96–1.90) 0.086
Infections prior to PID diagnosis
No* 1.0 1.0
Yes 0.62(0.36–1.07) 0.086 1.66(0.87–3.17) 0.125
Acute illness in past 12 months
No* 1.0 1.0
Yes 0.45(0.32–0.64) 0.0001 1.20(1.24–3.21) 0.005
Limitation of physical activity
None* 1.0 1.0
Slight 0.28(0.20–0.40) 0.0001 2.92(1.66–5.14)
Moderate 0.13(0.07–0.23) 0.0001 14.16(7.92–25.31) 0.0001
Severe 0.14(0.04–0.50) 0.003 51.37(24.11–109.41) 0.0001
Hospitalization in past 12 months
No* 1.0 1.0
Yes 0.53(0.36–0.77) 0.001 1.48(1.05–2.07) 0.025
Hepatitis
No* 1.0 1.0
Yes 0.51(0.23–1.17) 0.114 1.74(0.93–3.25) 0.081
Other chronic disease
No* 1.0 1.0
Yes 0.56(0.40–0.78) 0.001 1.70(1.21–2.36) 0.002
Access to specialist care as needed
No* 1.0 1.0
Yes 2.54(1.27–5.06) 0.008 0.79(0.49–1.27) 0.325
Physician Specialty
Others* 1.0 1.0
Immunology 0.96(0.69–1.34) 0.813 0.68(0.49–0.94) 0.020
Regular IVIG treatment
No* 1.0 1.0
Yes 1.61(1.07–2.42) 0.023 1.01(0.67–1.53) 0.951
*Reference
Significance level p<0.05
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sampling frame has always been unique; patients who either
have been added to the database since the last patient survey,
or those who have never participated in an IDF National Pa-
tient Survey before. This provided the ability to track down
how the patient population known to IDF, may change over
time by administering periodic surveys.
Patients’ own evaluation of their health is a very simple
health measure with important links to patient satisfaction and
quality of life [28]. As in most other studies, PH was based on
the reply to the global question BHow would you describe your
current health status?^ This has been described as a valid, single
measure of health status as it is associated with both disease and
subjective self-assessment [29,30]. Perceived health has been
demonstrated as predictive of objective health measures includ-
ing disease burden, health care service utilization, and mortality
[3,12,31–33]. A large-scale study of PH in PID employing
multivariate analyses has to our knowledge not been performed
and thus presents the possibility to truly appreciate what affects
patient perceptions of health in this rare disease population.
Our results highlight a number of factors as being signifi-
cant drivers of PH in PID patients including education level,
age, acute and chronic disease, hospitalizations, limitation in
physical activity, Bon demand^ access to specialist care, the
specialty of the physician caring for the patient, and regular
IVIG replacement therapy.
Several studies demonstrate significant associations between
sociodemographic factors and PH, including age, gender and
socioeconomic status [5,34,35]. The age distribution of the PID
patient population, and the mean age of PID patients studied
confirm that PID is not simply pediatric condition. In terms of
age distribution, the respondents to the 2002 IDF survey are
slightly different from other existing databases and registries
[36]. The registries aim to cover all the cases occurring in the
country, but age distribution in registries depends on the nature
of the contributing centers with most of the cases diagnosed in
children (e.g., the median age at diagnosis in the French registry
is 3.3 years) in some registries, whereas others have a majority
of adult cases (e.g., the median age in the Australian registry is
31 years) [37]. Comparing IDF database to USIDNET, another
U.S. database, the current age of the patients in the USIDNET
registry is 30 years. Based on the IDF data, the average age at
which patients were diagnosed with PID was the same as to
what the current age of the patient was in USIDNET, which
was 30 years (personal communication). So the average age of
PID patients in both U.S. databases are similar to each other.
In our study, age was a significant determinant of PH among
PID patients, but only when comparing EVG-PH to G-PH.
Our finding suggests that older patients are less likely to have
EVG-PH compared to G-PH. This may be due to the fact that
in general elderly are more likely to have health problems [33],
therefore likely not perceiving their health as excellent or very
good. There are other cross-sectional, population based studies
reporting of good PH decreased with age [38,39]. In addition
to age, the only other sociodemographic characteristic, which
was associated with PH in our study, was education level.
Patients with college and higher education were more likely
to report P-PH. There are inconsistent findings regarding the
link between PH and education status. Our result is in contrast
with some published literature [40,41] but consistent with few
others [42]. It has been suggested that individuals with higher
education might have more health knowledge or contact with
health services, making them more accurate predictors of their
own health status. Highly educated individuals, however,
may have higher expectations about their quality of life and
in some research have been linked to being more frequently
dissatisfied with their health [43]. In addition, people with
higher education levels have been documented as having
greater stress levels, which could have a negative impact on
PH [24]. In fact, a Bdose–response^ relation between PH and
stress is well documented [44].
Chronic diseases are a particular concern within medicine
and have been subject of substantive research as they may last
for a patient’s entire lifetime, require multiple physician visits,
have acute exacerbations necessitating hospital admissions, and
leave sequelae. Our findings in PID patients align with previous
reports, as patients with chronic disease were more likely to
have P-PH compared to patients who reported G-PH. They
were also far less likely to report EVG-PH when compared to
patients reporting G-PH. Several reports document negative
impact of chronic disease on PH [45,46]. In addition, PH can
predict onset of chronic disease [12]. In a longitudinal study of
healthy late midlife U.S. adults, respondents with higher PH at
baseline were less likely to experience subsequent first-time
chronic disease including arthritis, diabetes, stroke, coronary
heart disease, and lung disease [47]. The relative impact of
different chronic diseases on the level of PH has been investi-
gated and results differ depending on the condition evaluated
[23,48]. As an example, chronic diseases including gastrointes-
tinal, neurological, renal and musculoskeletal disorders had
more negative impact on PH compared to some other chronic
diseases such as asthma and diabetes [49]. As an important
limitation and like other data in our study, chronic conditions
were self-reported. These self reports also did not address
individual chronic diseases comprehensively, which would
be important to discern as particular chronic conditions
have the potential to contribute substantively to PH.
Hospital admission is a known significant driver of PH and
visa-versa and thus the fact that we identified it as an influence
upon PH in PID is not a surprise. In a cross-sectional study of
1678 older diabetes patients PH status was an independent
predictor of hospitalization in the following year [50]. A longi-
tudinal study in Sweden, identified associations between PH
and hospital admission in men, but not women, which were
attributed to the age differences and follow-up time [51].
Physical health, as might be expected, has consistently
been identified as a major predictor of PH [52,53].
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Longitudinal as well as cross-sectional studies have defined a
significant link between acute illness and PH independent of
the subjects’ chronic illnesses, which are in line with our find-
ings [54,55]. On another note, impact of acute illnesses on PH
may not be significant in younger and generally healthy pa-
tients [56].
We also found that limitation of physical activity was a
very strong predictor of PH in PID. Furthermore, the degree
of the limitation had significant impact on PH with increasing
activity limitation significantly decreasing the odds of G-PH.
This suggests that the largest contribution to PH among PID
patients derives from the extent to which patients can do what
they need and want to do. This finding is consistent with
results of several studies performed in other diseases
[57,58]. Along these lines, it has been reported that a patient’s
perception of disease related to musculoskeletal system was
the best predictor of PH in both men and women [59], and the
impact of limitations increases with age [60]. Importantly dai-
ly activity is an indicator of independent living [61], and lim-
itation can also predict decline in PH across age groups [62].
Thus, physical activity and perceived limitation likely repre-
sent an important focus area to promote improved PH in PID
patients and warrant further targeted study.
Our observation of the strong influence of Bon demand^
access to specialist care upon a PID patient’s PH is also con-
sistent with previous studies in other diseases [63]. When
compared to other measures of patient satisfaction such as
provider and quality of care received, access to care was found
to be more strongly associated with PH [28]. Moreover, al-
though not consistent across the literature [64] patients who
visited specialists were more satisfied with their health status
[28]. We observed only a weak association between PH and
physician specialty with patients seeing an immunologist
reporting less P-PH. This suggests at least some importance
to PID patients having access to specialized clinical immunol-
ogists with regards to their optimal PH.
Many patients with PID are faced with the challenge of life-
long therapy with regular IgG replacement intravenously or
subcutaneously in order to reduce susceptibility to and sever-
ity of infections. Studies demonstrated improved PH and
health related quality of life after initiation of IgG replacement
therapy, whichwas attributed to decreased infection frequency
[65,66]. Similarly, we found that regular IVIG replacement
was significantly associated with EVG-PH. The fact that a
specific and indicated therapy links to improved PH is impor-
tant to be cognizant of in making treatment decisions as PH is
a strong indicator of future health [58]. Thus patients for
whom IgG replacement therapy is indicated should be provid-
ed this therapy.
Despite the underlying immune deficiency, about two
thirds of patients in our study reported EVG-PH. A previous
study of adults with XLA found that with the exception of
their PH, patients had a comparable quality of life to that of
the general population [26]. This suggests that although XLA
has impact on patients’ daily lives as determined by missed
school/work days or hospitalizations, they can be moderately
healthy and lead productive lives [67]. On the contrary, in a
study of pediatric XLA patients, perceived psychosocial
health was poor despite good perceived physical health [27].
That said, P-PH and reduced family activities in children with
PID have been previously identified and attributed to frequent,
or serious infections and limitations of physical activity [68].
Differences between adults and children with PID may par-
tially be explained by age-related adaptation and development
of coping mechanisms, thus presenting potential strategies to
explore through additional research to improve PH. Perceived
health is also likely to be a feature of the underlying PID as PH
has been found to be lower in CVID as opposed to XLA
patients [67,69].
Our findings capture PID patients’ own experiences and
views of their health in the context of their disease. As such,
they indicate that clinical practice should ensure that treatment
plans and evaluations focus on the patient rather than the dis-
ease. In fact, clinicians could use PH assessment as a tool to
uncover patients’ problems, and unmet health needs. The po-
tential benefit of using PH measures in clinical practice is that
after problems are identified, further care decisions could be
linked to patients’ priorities and preferences [70]. This can
positively drive PH, which is again a significant predictor of
future health [58].
In a large study of adults positive PH changes were asso-
ciated with better functional well-being and greater survival
odds later in life [71]. Unden et al. suggested that irrespective
of physician’s rating of patient’s health during an office visit,
those with Bpoor^ PH, perceived lower social and mental
well-being, more somatic conditions, and worse coping abil-
ities [10]. Perceived health measures seem to make it practical
to look beyond traditional measures of biological functioning
to larger issues of functioning and well-being.
Knowledge of a patient’s PH could allow for clinical plan-
ning that takes into account all of the patient’s needs. As some
drivers of PH, including chronic/acute disease, and limitation
of physical activity significantly influenced PH, the establish-
ment of multidisciplinary health care teams to provide better
outpatient and home care services might be helpful for PID
patients and certainly worthy of further study with regards to
PH. We would suggest that better recognizing the factors that
drive PH in PID patients can guide improvements in clinical
care and help identify patient health needs. For example, given
our findings, interventions to increase physical activity may
help improve patients’ PH. Similarly; improving health-care
access to an immunologist might serve the same purpose.
Based upon our findings, we also suggest a distinct potential
value to regular preventive screenings to preempt an acute
disease, as well as encouragement of regular IgG replacement
therapy for patients in whom it is indicated. These should all
J Clin Immunol (2015) 35:638–650 647
be considered as possible ways to improve PH in PID patients,
which again is a known of predictor of future health [58]. In
addition, we would recommend a single question assessing a
patient’s PH be incorporated into the routine data collected
during a clinic visit to allow predictive healthcare modeling.
To the best of our knowledge, this is the first study analyz-
ing PH in general among patients, and parents of patients with
a variety of PID diagnoses based on a national U.S. sample.
One of the strengths of our study was that it was based on data
derived from a national patient-based survey and data covered
several self-reportedmedical history items. It also captured the
respondents’ own views of their health. There are limitations,
however, including that we used a cross-sectional survey,
which makes it difficult to establish the causal relationship
between PH and the factors identified. Because of the cross-
sectional nature of the survey, analyseswere limited to the PID
diagnoses present at the time of the survey and the impact of
other domains specific to that time. Accordingly, our discus-
sion of the trajectories does not contain a comparison group.
Also, the data upon which our study was based was self-
reported and not independently verified. Thus, there is a pos-
sibility of information bias. Finally, selection bias, may have
selected for respondents that may have been more health con-
scious, and therefore, more likely to report better PH. Alter-
natively, non-respondents may have been in poor health. Al-
though random assignment is preferable for unbiased popula-
tion estimates, and pediatric survey instruments are available,
the survey our data was based on did not target children di-
rectly to fill out the distributed surveys. Instead parents/care
givers were asked to respond on behalf of children. This sur-
vey procedure also introduces some selection bias towards
older respondents in households with multiple individuals
with PID. The selection bias may be minimized utilizing a
pediatric survey tool for future studies. In some cases in sur-
veys‚ one might ask the same questions of the parent-proxy
and of the child. This essentially means having at least two
surveys completed for each minor child, one from the proxy
and one from the child. Although it might be interesting to
compare the results, determining which answer to use if there
are differences between responses for a child is problematic.
Additionally, the cost involved to conduct the survey with
multiple instruments for a family, both in complexity, poten-
tial respondent burden and in true monetary costs would be
beyond the scope of the goals for the survey.
Our results, however, define some relevant signal and cre-
ate rationale for further evaluation of PH in PID. We propose
that a longitudinal study is needed to further clarify contribu-
tion of various factors to PH of patients with PID.
The strength of measures of general health perceptions lies
in their subjectivity and that patient values will help shape the
goals and means of medical care [72]. Our results suggest that
clinical care of patients with PID should be tailored to the
patients’ specific characteristics and needs to achieve better
patient outcomes. As patient outcomes research progresses,
each step in this direction brings medicine closer to pursuing
Bwhat really matters to our patients?^ rather than Bwhat is the
matter with our patients?^
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